In addition, AKT1 hotspot E17K mutations were found to be significantly more frequent in SF3B1 K700E mutated tumours (4/16) than in matched wild-type cancers (0/32, p = 0.009353, Fisher's exact test). This evidence concerns the gene SF3B1 and cancer.